Allergic Rhinitis
Conditions
Interventions
Treatment group:Acupuncture at Neiyingxiang Acupoint
Control group 1:Acupuncture at Yingxiang Acupoint
Control group 2:Fluticasone Propionate Nasal Spray
Sponsors
Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Patients who meet the diagnostic criteria for perennial allergic rhinitis. 2. No gender limit, aged between 18 and 65 years. 3. The course of disease is more than one year. 4. Informed consent, voluntary subjects, the process of obtaining informed consent conforms to ethical principles.
Exclusion criteria
Exclusion criteria: 1. Upper respiratory tract infection, eosinophilia, vasomotor rhinitis, nasal polyps, bronchitis, pneumonia, asthma. 2. Pregnant and lactating patients. 3. Patients with serious primary heart, liver, lung, kidney, blood diseases and diabetes or serious diseases affecting their survival. 4. Those who cannot give full informed consent due to intellectual or behavioral disabilities. 5. Suspected or confirmed history of alcohol and drug abuse. 6. Patients who are taking oral or topical glucocorticoids. 7. Accept other clinical trials within 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Allergic rhinitis nasal symptom score;Visual nasal symptoms analog scale scores;Quality of life questionnaire for rhinoconjunctivitis; | — |
Secondary
| Measure | Time frame |
|---|---|
| Scale item score; | — |
Countries
China
Contacts
Public ContactLi Lei
China Academy of Chinese Medical Science
Outcome results
None listed